| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosome binding | 1.16e-06 | 98 | 110 | 7 | GO:0031491 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.99e-06 | 229 | 110 | 9 | GO:0003714 | |
| GeneOntologyMolecularFunction | histone H2BS36 kinase activity | 3.01e-05 | 2 | 110 | 2 | GO:0140823 | |
| GeneOntologyMolecularFunction | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity | 3.01e-05 | 2 | 110 | 2 | GO:0047322 | |
| GeneOntologyMolecularFunction | histone H2B kinase activity | 3.01e-05 | 2 | 110 | 2 | GO:0140998 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPEF1 SPATA31A3 DCDC1 SGK1 STXBP5 SPTA1 SPATA31A7 RDX GBP3 SPATA31A5 MSN ADORA2A SPATA31A1 AP1G1 PLEKHM2 PLEKHG3 PRKAA1 NLRP5 | 3.03e-05 | 1099 | 110 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 3.41e-05 | 67 | 110 | 5 | GO:0031492 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | KDM5B H2AZ2 SEPTIN4 NAB2 GON4L CHD1L PARP14 HDAC7 ST13 AP4E1 IGF2BP3 MIDN MTA1 AP1G1 AASS PRKAA2 SMARCA4 MAP2K1 MAP2K2 HDAC1 | 4.62e-05 | 1356 | 110 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin binding | H2AZ2 CHD1L HDAC7 HP1BP3 MTA1 GLI2 SUV39H1 PRKAA1 PRKAA2 SMARCA4 H2AZ1 MACROH2A2 CHD6 HDAC1 | 5.49e-05 | 739 | 110 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 1.30e-04 | 47 | 110 | 4 | GO:0004712 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.82e-04 | 363 | 110 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | KDM5B NAB2 GON4L CHD1L PARP14 HDAC7 ST13 AP4E1 IGF2BP3 MTA1 AP1G1 AASS PRKAA2 SMARCA4 MAP2K1 MAP2K2 HDAC1 | 1.99e-04 | 1160 | 110 | 17 | GO:0030674 |
| GeneOntologyMolecularFunction | histone modifying activity | 2.78e-04 | 229 | 110 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | actin binding | SPEF1 SPATA31A3 SPTA1 SPATA31A7 RDX GBP3 SPATA31A5 MSN SPATA31A1 PLEKHG3 | 3.17e-04 | 479 | 110 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 3.27e-04 | 167 | 110 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 5.93e-04 | 30 | 110 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 5.93e-04 | 30 | 110 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 8.10e-04 | 446 | 110 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 9.09e-04 | 78 | 110 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.10e-03 | 37 | 110 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 1.31e-03 | 10 | 110 | 2 | GO:0004679 | |
| GeneOntologyMolecularFunction | protein kinase activity | CDK16 CDK17 SGK1 CDKL1 FRK PRKAA1 PRKAA2 TSSK3 MAP2K1 MAP2K2 | 1.77e-03 | 600 | 110 | 10 | GO:0004672 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DPAGT1 CDK16 CDK17 TUT4 SGK1 PARP14 CDKL1 FRK PRKAA1 PRKAA2 TSSK3 MAP2K1 MAP2K2 | 1.95e-03 | 938 | 110 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 2.25e-03 | 13 | 110 | 2 | GO:0005078 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 2.28e-03 | 100 | 110 | 4 | GO:0030527 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 3.47e-03 | 55 | 110 | 3 | GO:0001046 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | KDM5B H2AZ2 BAZ2B CHD1L HDAC7 SMYD2 HP1BP3 MTA1 SUV39H1 PRKAA1 PRKAA2 SMARCA4 H2AZ1 MACROH2A2 CHD6 HDAC1 | 1.74e-06 | 741 | 109 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of early endosome to late endosome transport | 3.35e-06 | 20 | 109 | 4 | GO:2000641 | |
| GeneOntologyBiologicalProcess | chromatin organization | KDM5B H2AZ2 BAZ2B CHD1L HDAC7 SMYD2 HP1BP3 MTA1 SUV39H1 PRKAA1 PRKAA2 SMARCA4 H2AZ1 MACROH2A2 CHD6 ZNF518B HDAC1 | 4.57e-06 | 896 | 109 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | cell morphogenesis | KLHL10 SGK1 STXBP5 PPFIA2 SPTA1 SMURF1 RDX MSN TGFB1 ADORA2A GLI2 ARHGAP44 SLIT3 PCDH15 SMARCA4 MAP2K1 ARHGEF26 MAP2K2 CDH8 | 1.47e-05 | 1194 | 109 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | KDM5B H2AZ2 BAZ2B CHD1L HDAC7 SMYD2 HP1BP3 MTA1 SUV39H1 PRKAA1 PRKAA2 SMARCA4 H2AZ1 MACROH2A2 CHD6 ZNF518B HDAC1 | 1.89e-05 | 999 | 109 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of protein localization | CDK16 CTDSPL2 SGK1 PPFIA1 RDX CEP192 MSN TGFB1 LRIG2 ADORA2A MIDN PLEKHM2 ARHGAP44 PRKAA1 PRKAA2 SLC9B2 MAP2K1 | 5.46e-05 | 1087 | 109 | 17 | GO:0032880 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | CDK16 CTDSPL2 SGK1 PPFIA1 RDX CEP192 MSN TGFB1 LRIG2 ADORA2A MIDN PLEKHM2 ARHGAP44 PRKAA1 PRKAA2 SLC9B2 MAP2K1 MAP2K2 | 6.28e-05 | 1212 | 109 | 18 | GO:0060341 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 1.03e-04 | 203 | 109 | 7 | GO:0045814 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 1.10e-04 | 47 | 109 | 4 | GO:0006476 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 1.41e-04 | 50 | 109 | 4 | GO:0045022 | |
| GeneOntologyBiologicalProcess | protein localization to lipid droplet | 1.65e-04 | 4 | 109 | 2 | GO:1990044 | |
| GeneOntologyBiologicalProcess | regulation of Golgi inheritance | 1.65e-04 | 4 | 109 | 2 | GO:0090170 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.78e-04 | 21 | 109 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | SEPTIN4 STXBP5 PPFIA2 RDX MSN TGFB1 ATAD1 AP1G1 ARHGAP44 PRKAA1 MAP2K1 MAP2K2 | 2.12e-04 | 667 | 109 | 12 | GO:0060627 |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 2.18e-04 | 103 | 109 | 5 | GO:0002088 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 2.19e-04 | 56 | 109 | 4 | GO:0098927 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 2.30e-04 | 163 | 109 | 6 | GO:0031507 | |
| GeneOntologyBiologicalProcess | protein deacylation | 2.51e-04 | 58 | 109 | 4 | GO:0035601 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 1.15e-04 | 49 | 107 | 4 | GO:0099523 | |
| GeneOntologyCellularComponent | presynapse | CDK16 SEPTIN4 STXBP5 PPFIA2 PPFIA1 ANKS1B PPFIA3 ADORA2A AP1G1 MPP4 ARHGAP44 SLC9B2 CDH8 SENP5 | 1.70e-04 | 886 | 107 | 14 | GO:0098793 |
| GeneOntologyCellularComponent | cytosolic region | 4.59e-04 | 70 | 107 | 4 | GO:0099522 | |
| GeneOntologyCellularComponent | axon | SEPTIN4 PPFIA2 SPTA1 PPFIA1 SMURF1 TGFB1 LRIG2 ADORA2A MPP4 PRKAA1 PRKAA2 MAP2K1 CDH8 | 6.27e-04 | 891 | 107 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | cell cortex | 6.46e-04 | 371 | 107 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | Barr body | 7.12e-04 | 8 | 107 | 2 | GO:0001740 | |
| GeneOntologyCellularComponent | presynaptic active zone | 7.97e-04 | 141 | 107 | 5 | GO:0048786 | |
| Domain | Liprin | 3.82e-06 | 6 | 109 | 3 | IPR029515 | |
| Domain | MACRO | 2.25e-05 | 10 | 109 | 3 | PS51154 | |
| Domain | Macro_dom | 2.25e-05 | 10 | 109 | 3 | IPR002589 | |
| Domain | AMPK_C | 3.37e-05 | 2 | 109 | 2 | IPR032270 | |
| Domain | AdenylateSensor | 3.37e-05 | 2 | 109 | 2 | PF16579 | |
| Domain | - | 3.66e-05 | 106 | 109 | 6 | 1.10.150.50 | |
| Domain | DUF4599 | 4.09e-05 | 12 | 109 | 3 | PF15371 | |
| Domain | DUF4599 | 4.09e-05 | 12 | 109 | 3 | IPR027970 | |
| Domain | SAM/pointed | 6.36e-05 | 117 | 109 | 6 | IPR013761 | |
| Domain | Protein_kinase_ATP_BS | CDK16 CDK17 SGK1 CDKL1 FRK PRKAA1 PRKAA2 TSSK3 MAP2K1 MAP2K2 | 7.53e-05 | 379 | 109 | 10 | IPR017441 |
| Domain | Histone_H2A_C | 1.24e-04 | 17 | 109 | 3 | IPR032454 | |
| Domain | Histone_H2A_C | 1.24e-04 | 17 | 109 | 3 | PF16211 | |
| Domain | ERM_C_dom | 2.01e-04 | 4 | 109 | 2 | IPR011259 | |
| Domain | DUF21 | 2.01e-04 | 4 | 109 | 2 | IPR002550 | |
| Domain | ERM | 2.01e-04 | 4 | 109 | 2 | PF00769 | |
| Domain | DUF21 | 2.01e-04 | 4 | 109 | 2 | PF01595 | |
| Domain | ERM | 2.01e-04 | 4 | 109 | 2 | IPR011174 | |
| Domain | Ser/Thr_kinase_AS | 2.45e-04 | 357 | 109 | 9 | IPR008271 | |
| Domain | S_TKc | 2.55e-04 | 359 | 109 | 9 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.71e-04 | 362 | 109 | 9 | PS00108 | |
| Domain | H2A | 3.15e-04 | 23 | 109 | 3 | SM00414 | |
| Domain | Histone_H2A | 3.15e-04 | 23 | 109 | 3 | IPR002119 | |
| Domain | PROTEIN_KINASE_ATP | CDK16 CDK17 SGK1 CDKL1 FRK PRKAA1 PRKAA2 TSSK3 MAP2K1 MAP2K2 | 3.55e-04 | 459 | 109 | 10 | PS00107 |
| Domain | Pkinase | 3.94e-04 | 381 | 109 | 9 | PF00069 | |
| Domain | BRK | 4.99e-04 | 6 | 109 | 2 | SM00592 | |
| Domain | BRK_domain | 4.99e-04 | 6 | 109 | 2 | IPR006576 | |
| Domain | BRK | 4.99e-04 | 6 | 109 | 2 | PF07533 | |
| Domain | Prot_kinase_dom | CDK16 CDK17 SGK1 CDKL1 FRK PRKAA1 PRKAA2 TSSK3 MAP2K1 MAP2K2 | 5.82e-04 | 489 | 109 | 10 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK16 CDK17 SGK1 CDKL1 FRK PRKAA1 PRKAA2 TSSK3 MAP2K1 MAP2K2 | 6.19e-04 | 493 | 109 | 10 | PS50011 |
| Domain | SAM_1 | 6.71e-04 | 68 | 109 | 4 | PF00536 | |
| Domain | KA1/Ssp2_C | 6.95e-04 | 7 | 109 | 2 | IPR028375 | |
| Domain | Moesin_tail | 6.95e-04 | 7 | 109 | 2 | IPR008954 | |
| Domain | SNF2_N | 8.48e-04 | 32 | 109 | 3 | IPR000330 | |
| Domain | SNF2_N | 8.48e-04 | 32 | 109 | 3 | PF00176 | |
| Domain | A1pp | 1.18e-03 | 9 | 109 | 2 | SM00506 | |
| Domain | Macro | 1.18e-03 | 9 | 109 | 2 | PF01661 | |
| Domain | Kinase-like_dom | CDK16 CDK17 SGK1 CDKL1 FRK PRKAA1 PRKAA2 TSSK3 MAP2K1 MAP2K2 | 1.27e-03 | 542 | 109 | 10 | IPR011009 |
| Domain | SAM | 1.76e-03 | 88 | 109 | 4 | SM00454 | |
| Domain | Hist_deacetyl | 1.79e-03 | 11 | 109 | 2 | PF00850 | |
| Domain | His_deacetylse_dom | 1.79e-03 | 11 | 109 | 2 | IPR023801 | |
| Domain | - | 1.79e-03 | 11 | 109 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 1.79e-03 | 11 | 109 | 2 | IPR000286 | |
| Domain | - | 1.93e-03 | 222 | 109 | 6 | 1.25.10.10 | |
| Domain | SAM_2 | 2.01e-03 | 43 | 109 | 3 | PF07647 | |
| Domain | SAM_DOMAIN | 2.32e-03 | 95 | 109 | 4 | PS50105 | |
| Domain | SAM | 2.51e-03 | 97 | 109 | 4 | IPR001660 | |
| Domain | SANT | 3.10e-03 | 50 | 109 | 3 | SM00717 | |
| Domain | Clathrin/coatomer_adapt-like_N | 3.37e-03 | 15 | 109 | 2 | IPR002553 | |
| Domain | Adaptin_N | 3.37e-03 | 15 | 109 | 2 | PF01602 | |
| Domain | Histone_H2A_CS | 3.37e-03 | 15 | 109 | 2 | IPR032458 | |
| Domain | SANT/Myb | 3.47e-03 | 52 | 109 | 3 | IPR001005 | |
| Domain | Histone | 4.28e-03 | 56 | 109 | 3 | PF00125 | |
| Domain | Histone_H2A/H2B/H3 | 4.28e-03 | 56 | 109 | 3 | IPR007125 | |
| Domain | ARM-like | 5.06e-03 | 270 | 109 | 6 | IPR011989 | |
| Pathway | WP_THYROXINE_THYROID_HORMONE_PRODUCTION | 8.59e-06 | 25 | 75 | 4 | M39353 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.99e-05 | 68 | 75 | 5 | MM14968 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.32e-05 | 17 | 75 | 3 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.32e-05 | 17 | 75 | 3 | MM14907 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.11e-04 | 18 | 75 | 3 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 1.11e-04 | 18 | 75 | 3 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.11e-04 | 18 | 75 | 3 | MM14703 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 1.11e-04 | 18 | 75 | 3 | M27043 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.55e-04 | 20 | 75 | 3 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.55e-04 | 20 | 75 | 3 | MM14991 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 2.05e-04 | 55 | 75 | 4 | M39685 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.37e-04 | 23 | 75 | 3 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.37e-04 | 23 | 75 | 3 | M12627 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.70e-04 | 24 | 75 | 3 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.70e-04 | 24 | 75 | 3 | M630 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY | 2.76e-04 | 5 | 75 | 2 | M49016 | |
| Pathway | WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION | 3.06e-04 | 25 | 75 | 3 | M39574 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.33e-04 | 175 | 75 | 6 | MM14941 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 3.47e-04 | 63 | 75 | 4 | MM14714 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 3.86e-04 | 27 | 75 | 3 | M287 | |
| Pathway | PID_RB_1PATHWAY | 3.91e-04 | 65 | 75 | 4 | M279 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 4.13e-04 | 6 | 75 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 4.13e-04 | 6 | 75 | 2 | MM15273 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 4.13e-04 | 6 | 75 | 2 | M47636 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 4.13e-04 | 6 | 75 | 2 | MM15627 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 4.24e-04 | 119 | 75 | 5 | M48309 | |
| Pathway | BIOCARTA_ERK_PATHWAY | 4.31e-04 | 28 | 75 | 3 | MM1391 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 4.40e-04 | 67 | 75 | 4 | MM15327 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.58e-04 | 121 | 75 | 5 | M872 | |
| Pathway | WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME | 4.78e-04 | 29 | 75 | 3 | M39890 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 4.92e-04 | 69 | 75 | 4 | M237 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.97e-04 | 272 | 75 | 7 | M29619 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 6.09e-04 | 73 | 75 | 4 | M321 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 6.75e-04 | 75 | 75 | 4 | MM14652 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | KDM5B H2AZ2 SGK1 SMURF1 HDAC7 SMYD2 CCND2 TGFB1 PRKAA1 PRKAA2 SMARCA4 HDAC1 | 6.90e-04 | 768 | 75 | 12 | MM14851 |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 6.93e-04 | 201 | 75 | 6 | M39605 | |
| Pathway | WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA | 7.04e-04 | 33 | 75 | 3 | M39800 | |
| Pathway | WP_LEPTIN_SIGNALING | 7.10e-04 | 76 | 75 | 4 | M39491 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 7.29e-04 | 134 | 75 | 5 | M3574 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY | 7.66e-04 | 8 | 75 | 2 | M47916 | |
| Pathway | WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1 | 9.81e-04 | 9 | 75 | 2 | M39481 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 9.87e-04 | 37 | 75 | 3 | M39756 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.08e-03 | 301 | 75 | 7 | MM15983 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.18e-03 | 87 | 75 | 4 | M27617 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 1.22e-03 | 10 | 75 | 2 | M47374 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 1.22e-03 | 10 | 75 | 2 | M47420 | |
| Pathway | WP_ETHANOL_METABOLISM_RESULTING_IN_PRODUCTION_OF_ROS_BY_CYP2E1 | 1.22e-03 | 10 | 75 | 2 | MM15821 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 1.22e-03 | 10 | 75 | 2 | M47735 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.33e-03 | 502 | 75 | 9 | MM14537 | |
| Pathway | WP_IL2_SIGNALING | 1.43e-03 | 42 | 75 | 3 | M39536 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.48e-03 | 157 | 75 | 5 | MM15226 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.49e-03 | 11 | 75 | 2 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.49e-03 | 11 | 75 | 2 | M47371 | |
| Pathway | BIOCARTA_LEPTIN_PATHWAY | 1.49e-03 | 11 | 75 | 2 | M18053 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS | 1.49e-03 | 11 | 75 | 2 | M27420 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 1.53e-03 | 43 | 75 | 3 | M39706 | |
| Pathway | WP_IL6_SIGNALING | 1.53e-03 | 43 | 75 | 3 | M39656 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 1.53e-03 | 43 | 75 | 3 | MM15864 | |
| Pathway | WP_INSULIN_SIGNALING | 1.61e-03 | 160 | 75 | 5 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 1.61e-03 | 160 | 75 | 5 | M39482 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.61e-03 | 160 | 75 | 5 | M27498 | |
| Pathway | WP_IL11_SIGNALING | 1.64e-03 | 44 | 75 | 3 | M39716 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 1.76e-03 | 97 | 75 | 4 | M48262 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.78e-03 | 12 | 75 | 2 | M47369 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 1.78e-03 | 12 | 75 | 2 | M47597 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 1.78e-03 | 12 | 75 | 2 | M47815 | |
| Pathway | WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY | 1.78e-03 | 12 | 75 | 2 | M45558 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.86e-03 | 46 | 75 | 3 | M39828 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.90e-03 | 99 | 75 | 4 | MM15905 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.97e-03 | 100 | 75 | 4 | MM15826 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 2.10e-03 | 13 | 75 | 2 | M47589 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 2.10e-03 | 13 | 75 | 2 | M89 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 2.11e-03 | 48 | 75 | 3 | M219 | |
| Pathway | WP_ENERGY_METABOLISM | 2.11e-03 | 48 | 75 | 3 | M39590 | |
| Pathway | WP_RETT_SYNDROME | 2.11e-03 | 48 | 75 | 3 | M39759 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 2.26e-03 | 439 | 75 | 8 | M42563 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 2.27e-03 | 104 | 75 | 4 | M39625 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M668 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M47384 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 2.44e-03 | 14 | 75 | 2 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 2.44e-03 | 14 | 75 | 2 | MM14667 | |
| Pathway | BIOCARTA_CDK5_PATHWAY | 2.44e-03 | 14 | 75 | 2 | MM1457 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.44e-03 | 14 | 75 | 2 | M47488 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 2.44e-03 | 14 | 75 | 2 | MM1489 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.51e-03 | 51 | 75 | 3 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.51e-03 | 51 | 75 | 3 | MM14499 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 2.61e-03 | 108 | 75 | 4 | M48078 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.63e-03 | 261 | 75 | 6 | MM15676 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | KDM5B H2AZ2 SGK1 SMURF1 HDAC7 SMYD2 CCND2 TGFB1 MTA1 PRKAA1 PRKAA2 SMARCA4 HDAC1 | 2.65e-03 | 1022 | 75 | 13 | MM15436 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 2.80e-03 | 15 | 75 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.80e-03 | 15 | 75 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 2.80e-03 | 15 | 75 | 2 | M47382 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.80e-03 | 15 | 75 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 2.80e-03 | 15 | 75 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 2.80e-03 | 15 | 75 | 2 | M47593 | |
| Pubmed | 1.47e-09 | 6 | 111 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.47e-09 | 6 | 111 | 4 | 25930072 | |
| Pubmed | 1.22e-08 | 24 | 111 | 5 | 32212159 | ||
| Pubmed | Lkb1 is required for TGFbeta-mediated myofibroblast differentiation. | 1.26e-07 | 4 | 111 | 3 | 18840652 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11823472 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 25425646 | ||
| Pubmed | Fluid shear stress-induced TGF-β/ALK5 signaling in renal epithelial cells is modulated by MEK1/2. | 1.26e-07 | 4 | 111 | 3 | 28168444 | |
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 19013515 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 35072799 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 19447520 | ||
| Pubmed | 3.67e-07 | 19 | 111 | 4 | 21965329 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CTDSPL2 BAZ2B CHD1L MSH3 HP1BP3 FSIP2 MTA1 SUV39H1 SMARCA4 PDS5A CHD6 HDAC1 | 5.99e-07 | 608 | 111 | 12 | 36089195 |
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 6.28e-07 | 6 | 111 | 3 | 21618221 | |
| Pubmed | 7.66e-07 | 157 | 111 | 7 | 30186101 | ||
| Pubmed | 1.10e-06 | 7 | 111 | 3 | 17373667 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 1639063 | ||
| Pubmed | 1.75e-06 | 8 | 111 | 3 | 21308864 | ||
| Pubmed | Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis. | 1.75e-06 | 8 | 111 | 3 | 15485920 | |
| Pubmed | 2.62e-06 | 9 | 111 | 3 | 12923177 | ||
| Pubmed | 2.89e-06 | 31 | 111 | 4 | 15217342 | ||
| Pubmed | CDK17 SEPTIN4 PPFIA2 SPTA1 PPFIA1 SMURF1 ANKS1B RDX PPFIA3 KANK2 ST13 HP1BP3 AP1G1 ARHGAP44 PRKAA1 SMARCA4 MAP2K1 | 2.96e-06 | 1431 | 111 | 17 | 37142655 | |
| Pubmed | Regulation of axonal morphogenesis by the mitochondrial protein Efhd1. | 3.74e-06 | 10 | 111 | 3 | 32414840 | |
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 26290144 | ||
| Pubmed | 3.74e-06 | 10 | 111 | 3 | 18952847 | ||
| Pubmed | Nucleosome adaptability conferred by sequence and structural variations in histone H2A-H2B dimers. | 3.74e-06 | 10 | 111 | 3 | 25731851 | |
| Pubmed | 4.37e-06 | 75 | 111 | 5 | 25593309 | ||
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 25362550 | ||
| Pubmed | 6.82e-06 | 12 | 111 | 3 | 21344388 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 6.82e-06 | 12 | 111 | 3 | 9624153 | |
| Pubmed | CDK16 CTDSPL2 RDX HEATR1 ST13 HP1BP3 MSN MTA1 PLEKHG3 ARHGAP44 SMARCA4 PDS5A ARHGEF26 | 7.51e-06 | 916 | 111 | 13 | 32203420 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 9.08e-06 | 150 | 111 | 6 | 28242625 | |
| Pubmed | Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. | 1.01e-05 | 2 | 111 | 2 | 9563949 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21673972 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 18801964 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21947382 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 32839348 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20465544 | ||
| Pubmed | Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. | 1.01e-05 | 2 | 111 | 2 | 19236843 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23905686 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12832465 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 32504885 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19014680 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 10840944 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 31540695 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 27600021 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23486478 | ||
| Pubmed | Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. | 1.01e-05 | 2 | 111 | 2 | 15878932 | |
| Pubmed | AMPK activation regulates neuronal structure in developing hippocampal neurons. | 1.01e-05 | 2 | 111 | 2 | 24295634 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22763120 | ||
| Pubmed | AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase. | 1.01e-05 | 2 | 111 | 2 | 22233421 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26625317 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26843621 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21209024 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 24855056 | ||
| Pubmed | Phosphorylated and dephosphorylated structures of pig heart, GTP-specific succinyl-CoA synthetase. | 1.01e-05 | 2 | 111 | 2 | 10873456 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26419588 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 28974562 | ||
| Pubmed | Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. | 1.01e-05 | 2 | 111 | 2 | 12546688 | |
| Pubmed | TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis. | 1.01e-05 | 2 | 111 | 2 | 21862631 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12788940 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 38019084 | ||
| Pubmed | The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma. | 1.01e-05 | 2 | 111 | 2 | 34347929 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21699731 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 17419998 | ||
| Pubmed | Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK. | 1.01e-05 | 2 | 111 | 2 | 31693892 | |
| Pubmed | Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice. | 1.01e-05 | 2 | 111 | 2 | 32213711 | |
| Pubmed | AMPK knockdown in placental trophoblast cells results in altered morphology and function. | 1.01e-05 | 2 | 111 | 2 | 25003940 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 29928235 | ||
| Pubmed | [AMPK as a Metabolic Intersection between Diet and Physical Exercise]. | 1.01e-05 | 2 | 111 | 2 | 30270274 | |
| Pubmed | AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. | 1.01e-05 | 2 | 111 | 2 | 21483791 | |
| Pubmed | MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response. | 1.01e-05 | 2 | 111 | 2 | 23735655 | |
| Pubmed | AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. | 1.01e-05 | 2 | 111 | 2 | 20399918 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 34767944 | ||
| Pubmed | The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma. | 1.01e-05 | 2 | 111 | 2 | 35069558 | |
| Pubmed | Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice. | 1.01e-05 | 2 | 111 | 2 | 26244519 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12091379 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 24665903 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 20830737 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22119190 | ||
| Pubmed | Protein expression alteration in hippocampus upon genetic repression of AMPKα isoforms. | 1.01e-05 | 2 | 111 | 2 | 33492732 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21527500 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 29038293 | ||
| Pubmed | Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia. | 1.01e-05 | 2 | 111 | 2 | 19383924 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21432774 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15284233 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 16186119 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26268732 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 37684630 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19156172 | ||
| Pubmed | Malignant potential of Barrett's esophagus: special reference to HDAC-1 and MTA-1 expression. | 1.01e-05 | 2 | 111 | 2 | 21661415 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12839928 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 27879319 | ||
| Pubmed | MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo. | 1.01e-05 | 2 | 111 | 2 | 16957420 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 34031393 | ||
| Pubmed | AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. | 1.01e-05 | 2 | 111 | 2 | 24652947 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 23288166 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19144315 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 28978947 | ||
| Pubmed | H2A.Z facilitates licensing and activation of early replication origins. | 1.01e-05 | 2 | 111 | 2 | 31875854 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 19500021 | ||
| Interaction | H3C3 interactions | CTDSPL2 BAZ2B CHD1L MSH3 HP1BP3 FSIP2 MIDN MTA1 SUV39H1 SMARCA4 PDS5A CHD6 HDAC1 | 2.49e-06 | 495 | 108 | 13 | int:H3C3 |
| Interaction | NFE2L2 interactions | 2.38e-05 | 159 | 108 | 7 | int:NFE2L2 | |
| Interaction | NUCKS1 interactions | 2.45e-05 | 220 | 108 | 8 | int:NUCKS1 | |
| Interaction | CBX1 interactions | 2.49e-05 | 288 | 108 | 9 | int:CBX1 | |
| Interaction | H2AZ1 interactions | H2AZ2 CHD1L PARP14 HP1BP3 MIDN MTA1 SMARCA4 H2AZ1 MACROH2A2 HDAC1 | 3.09e-05 | 371 | 108 | 10 | int:H2AZ1 |
| Interaction | MID1IP1 interactions | 4.53e-05 | 73 | 108 | 5 | int:MID1IP1 | |
| Interaction | H2BC8 interactions | EXOSC10 CTDSPL2 GON4L CHD1L MSH3 HEATR1 HP1BP3 SMARCA4 H2AZ1 PDS5A MACROH2A2 CHD6 | 6.09e-05 | 576 | 108 | 12 | int:H2BC8 |
| Interaction | PARP1 interactions | SEPTIN4 CTDSPL2 SPTA1 CHD1L MSH3 HEATR1 KANK2 HDAC7 HP1BP3 MIDN MTA1 AASS PRKAA1 SMARCA4 H2AZ1 PDS5A MACROH2A2 CHD6 HDAC1 | 6.69e-05 | 1316 | 108 | 19 | int:PARP1 |
| Interaction | YWHAZ interactions | CDK16 CDK17 KDM5B SGK1 PPFIA2 SPTA1 PPFIA1 CEP192 PPFIA3 KANK2 HDAC7 MSN FSIP2 AASS PLEKHG3 PRKAA1 PRKAA2 MAP2K1 MAP2K2 | 6.90e-05 | 1319 | 108 | 19 | int:YWHAZ |
| Cytoband | 4p14 | 1.47e-04 | 42 | 111 | 3 | 4p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.61e-04 | 8 | 111 | 2 | chr9q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p14 | 5.89e-04 | 67 | 111 | 3 | chr4p14 | |
| GeneFamily | Cyclin dependent kinases | 1.54e-04 | 26 | 73 | 3 | 496 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 3.33e-04 | 7 | 73 | 2 | 653 | |
| GeneFamily | Sterile alpha motif domain containing | 4.41e-04 | 88 | 73 | 4 | 760 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.03e-03 | 12 | 73 | 2 | 1305 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.28e-03 | 53 | 73 | 3 | 532 | |
| GeneFamily | NLR family | 4.54e-03 | 25 | 73 | 2 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 4.54e-03 | 25 | 73 | 2 | 994 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 1.96e-06 | 200 | 109 | 8 | M8959 | |
| Coexpression | HU_ANGIOGENESIS_DN | 1.68e-05 | 37 | 109 | 4 | M18833 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-07 | 183 | 111 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.68e-07 | 188 | 111 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-07 | 191 | 111 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 7.09e-07 | 200 | 111 | 7 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.06e-06 | 160 | 111 | 6 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.66e-06 | 178 | 111 | 6 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.03e-06 | 180 | 111 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.03e-06 | 180 | 111 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.22e-06 | 181 | 111 | 6 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.97e-06 | 189 | 111 | 6 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.97e-06 | 189 | 111 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-06 | 190 | 111 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 191 | 111 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.98e-06 | 193 | 111 | 6 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | 15-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 9.25e-06 | 194 | 111 | 6 | 5c1218d239c88082496924653ed2a092dc44a906 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 111 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 5.52e-05 | 163 | 111 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.68e-05 | 164 | 111 | 5 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.68e-05 | 164 | 111 | 5 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.68e-05 | 164 | 111 | 5 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-05 | 167 | 111 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 168 | 111 | 5 | b08458164d270d625b8ee390122d1c2ce8c653db | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-05 | 171 | 111 | 5 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-05 | 171 | 111 | 5 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.12e-05 | 172 | 111 | 5 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-05 | 174 | 111 | 5 | b1bcd5f4505d2ccef4183fcfbf1de81964b3f9e0 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 175 | 111 | 5 | 0a01e0104cfa3091bc05b0f1d087c941688169a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | f99500c4a590e5152ded5862690f7fa614d64a80 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | 3f2934c5f8816a7b7a6aef8d2f83ebf7b2b693bf | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-05 | 179 | 111 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | 7d61466181ab73088de3ec8a129d7cfa8cac7ecc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | 6c98ce32cb55cf9cee557449e41b23bdb22f5efd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.05e-05 | 181 | 111 | 5 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.05e-05 | 181 | 111 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 182 | 111 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 182 | 111 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.53e-05 | 183 | 111 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | HSPCs-Ery/Mk_prog.|HSPCs / Lineage and Cell class | 9.53e-05 | 183 | 111 | 5 | 59cfb02143b6b54dfca7560562e064948f0340ca | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 185 | 111 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 185 | 111 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 185 | 111 | 5 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 185 | 111 | 5 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 185 | 111 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Entopeduncular-Endothelial|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 188 | 111 | 5 | 94774652fd42bad5012356672ffac8b6d2c22d37 | |
| ToppCell | MS-CD8-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 1.08e-04 | 188 | 111 | 5 | 2f0e2c7d79ee2d69a5d908c0247dc950c056c30a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 189 | 111 | 5 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 189 | 111 | 5 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 189 | 111 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 191 | 111 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.16e-04 | 191 | 111 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 192 | 111 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 192 | 111 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 95e64b9580d30c28702639a043a8b72ce1cadeb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 193 | 111 | 5 | 5879efb38e6b3bf8c33c9a773632b1d726e3c153 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 193 | 111 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-04 | 193 | 111 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 193 | 111 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 193 | 111 | 5 | 725115a5ce3ef520b3ef469e96b8219b4c723fdd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 193 | 111 | 5 | abd7bcf318a2d895d8811c2ada8bfb4314fca3b1 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 194 | 111 | 5 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 194 | 111 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 194 | 111 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | Posterior_cortex-Endothelial|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 195 | 111 | 5 | 988e3449691cc228cb55e5e30355136c97b12262 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 196 | 111 | 5 | cda3681f032f740cb09c64c62b9153cb62dbb5d2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 196 | 111 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 196 | 111 | 5 | b55aa507429ddce89ad4f42ab6daeca2f34fd676 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 196 | 111 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 196 | 111 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 197 | 111 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.35e-04 | 197 | 111 | 5 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.38e-04 | 198 | 111 | 5 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.38e-04 | 198 | 111 | 5 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 198 | 111 | 5 | 77288df94286382170a266474ab85960519e8449 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 198 | 111 | 5 | 2ee195f20a4f91fa1dcad9eaf96d6086e3b0fb4a | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.38e-04 | 198 | 111 | 5 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.41e-04 | 199 | 111 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.41e-04 | 199 | 111 | 5 | 2c5ad62919c64ea0242e0984bb9932d2d975f4e3 | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class | 1.41e-04 | 199 | 111 | 5 | 39c4adef3e02f948414f866aa22ac76f44b7b7db | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-04 | 200 | 111 | 5 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-04 | 200 | 111 | 5 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| Drug | DB08184 | 1.34e-06 | 167 | 108 | 8 | CID009547945 | |
| Drug | butyrolactone I | 2.62e-06 | 128 | 108 | 7 | CID000123740 | |
| Drug | trapoxin | 8.21e-06 | 58 | 108 | 5 | CID000121875 | |
| Drug | SK-7041 | 9.71e-06 | 60 | 108 | 5 | CID006918714 | |
| Drug | AC1L1FWN | 1.29e-05 | 227 | 108 | 8 | CID000003425 | |
| Drug | TAK 733 | 2.23e-05 | 2 | 108 | 2 | ctd:C558666 | |
| Drug | N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | 2.23e-05 | 2 | 108 | 2 | ctd:C544830 | |
| Drug | BLX 1002 | 2.23e-05 | 2 | 108 | 2 | ctd:C542815 | |
| Drug | NSC24559 | 2.56e-05 | 122 | 108 | 6 | CID000029051 | |
| Drug | inchinko-to | 3.64e-05 | 14 | 108 | 3 | ctd:C078038 | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 3572_DN | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 4836_DN | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 3532_DN | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; HL60; HG-U133A | 4.64e-05 | 199 | 108 | 7 | 1790_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.79e-05 | 200 | 108 | 7 | 3405_DN | |
| Drug | AC1NV99J | 5.56e-05 | 16 | 108 | 3 | CID005474719 | |
| Disease | small intestine adenocarcinoma (is_implicated_in) | 3.75e-05 | 3 | 105 | 2 | DOID:4906 (is_implicated_in) | |
| Disease | Hematopoietic Neoplasms | 7.49e-05 | 4 | 105 | 2 | C0376544 | |
| Disease | Impaired glucose tolerance | 9.51e-05 | 25 | 105 | 3 | C0271650 | |
| Disease | body weight | CDK17 CNNM2 ANKS1B ETV6 GON4L CEP192 CHD1L PPFIA3 CCND2 IGF2BP3 PTPRR SLIT3 PCDH15 ARHGEF26 | 1.53e-04 | 1261 | 105 | 14 | EFO_0004338 |
| Disease | breast cancer (is_implicated_in) | 2.04e-04 | 150 | 105 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | multiple myeloma (is_marker_for) | 2.87e-04 | 36 | 105 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Unipolar Depression | 3.36e-04 | 259 | 105 | 6 | C0041696 | |
| Disease | RASopathy (implicated_via_orthology) | 4.44e-04 | 9 | 105 | 2 | DOID:0080690 (implicated_via_orthology) | |
| Disease | alopecia areata (is_marker_for) | 5.54e-04 | 10 | 105 | 2 | DOID:986 (is_marker_for) | |
| Disease | Heart Diseases | 5.95e-04 | 46 | 105 | 3 | C0018799 | |
| Disease | granulosa cell tumor (is_marker_for) | 6.76e-04 | 11 | 105 | 2 | DOID:2999 (is_marker_for) | |
| Disease | Noonan Syndrome 1 | 6.76e-04 | 11 | 105 | 2 | C4551602 | |
| Disease | Turner Syndrome, Male | 6.76e-04 | 11 | 105 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 6.76e-04 | 11 | 105 | 2 | C1527404 | |
| Disease | Occupational Diseases | 6.76e-04 | 11 | 105 | 2 | C0028797 | |
| Disease | factor VIII measurement, coronary artery disease | 7.24e-04 | 113 | 105 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Hematologic Neoplasms | 8.09e-04 | 12 | 105 | 2 | C0376545 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 8.51e-04 | 118 | 105 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | response to TNF antagonist | 9.52e-04 | 54 | 105 | 3 | EFO_0004653 | |
| Disease | Cakut | 9.54e-04 | 13 | 105 | 2 | C1968949 | |
| Disease | biliary atresia (is_marker_for) | 1.11e-03 | 14 | 105 | 2 | DOID:13608 (is_marker_for) | |
| Disease | Diabetic Neuralgia | 1.11e-03 | 14 | 105 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 1.11e-03 | 14 | 105 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 1.11e-03 | 14 | 105 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 1.11e-03 | 14 | 105 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 1.11e-03 | 14 | 105 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 1.11e-03 | 14 | 105 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 1.11e-03 | 14 | 105 | 2 | C0271685 | |
| Disease | total brain volume change measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0021504 | |
| Disease | Diabetic Polyneuropathies | 1.11e-03 | 14 | 105 | 2 | C0271680 | |
| Disease | sickle cell anemia (is_marker_for) | 1.11e-03 | 14 | 105 | 2 | DOID:10923 (is_marker_for) | |
| Disease | Diabetic Asymmetric Polyneuropathy | 1.11e-03 | 14 | 105 | 2 | C0393835 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Cardiomyopathies | 1.22e-03 | 130 | 105 | 4 | C0878544 | |
| Disease | Uremia | 1.65e-03 | 17 | 105 | 2 | C0041948 | |
| Disease | mean corpuscular hemoglobin concentration | DPAGT1 CNNM2 H2AZ2 SEPTIN4 CTDSPL2 SPTA1 ETV6 GON4L HDAC7 CDKL1 PRKAA1 | 1.94e-03 | 1105 | 105 | 11 | EFO_0004528 |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 2.06e-03 | 19 | 105 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 2.06e-03 | 19 | 105 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 2.06e-03 | 19 | 105 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 2.06e-03 | 19 | 105 | 2 | C0587248 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.06e-03 | 19 | 105 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.06e-03 | 19 | 105 | 2 | C2936783 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.10e-03 | 71 | 105 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 2.19e-03 | 72 | 105 | 3 | DOID:9744 (is_marker_for) | |
| Disease | prostate cancer (is_marker_for) | 2.38e-03 | 156 | 105 | 4 | DOID:10283 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 2.43e-03 | 157 | 105 | 4 | DOID:9256 (is_marker_for) | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 2.45e-03 | 75 | 105 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | LEOPARD Syndrome | 2.77e-03 | 22 | 105 | 2 | C0175704 | |
| Disease | impotence (biomarker_via_orthology) | 2.77e-03 | 22 | 105 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Septicemia | 3.29e-03 | 24 | 105 | 2 | C0036690 | |
| Disease | Sepsis | 3.29e-03 | 24 | 105 | 2 | C0243026 | |
| Disease | Severe Sepsis | 3.29e-03 | 24 | 105 | 2 | C1719672 | |
| Disease | Pyemia | 3.29e-03 | 24 | 105 | 2 | C0034189 | |
| Disease | Noonan Syndrome | 3.29e-03 | 24 | 105 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NILDPKKQLVRHRLF | 361 | Q05D32 | |
| IIHKVLKRENLLNIL | 871 | A4D0V7 | |
| KIIRSHVLRQQEPFK | 301 | P29274 | |
| IKREIQNLKLFRHPH | 61 | P54646 | |
| LKVLHLRGIREKALQ | 1731 | Q9UIF8 | |
| DLKVKRITPRHLQLA | 76 | Q71UI9 | |
| NKKARIAPRHILLAV | 71 | Q9P0M6 | |
| KVLIQPSNRRAIHDK | 56 | Q9UDR5 | |
| RRPKVKHILKNLRII | 86 | Q8N4C9 | |
| KHILKNLRIIAAPRR | 91 | Q8N4C9 | |
| QHRRPLIQCLLKEFK | 836 | A6QL63 | |
| NQNVEPHKRLLKVRS | 266 | Q96DR7 | |
| PLHKAAVQLNRKILE | 86 | A6NK59 | |
| KLIQKNVPRRHSLRN | 96 | Q7Z4U5 | |
| PSALKTLQQKLRLHI | 1066 | Q9UPM8 | |
| LKEVQPRAQKIAEHR | 221 | P50502 | |
| KLRVDIRPQLLKNAL | 291 | Q5SSJ5 | |
| RKLIHLEIKPAIRNQ | 96 | Q02750 | |
| KLIHLEIKPAIRNQI | 101 | P36507 | |
| NHVLPLKRLILKLDI | 66 | Q9UPQ7 | |
| IRSTLIPILHQKAKR | 716 | Q29RF7 | |
| RLKKTDIPLLQRLLQ | 276 | Q6ZTQ3 | |
| RLLPQRVLEQHKLTK | 151 | P35241 | |
| KLPQQREKLSLIRKH | 166 | P30279 | |
| HFRKLVPQLVRILKN | 211 | O43747 | |
| NVLKINLIGHRKRIL | 926 | Q7Z6G8 | |
| LLQHILKQRKPRILF | 116 | P41212 | |
| IRMHLQEIRKILKNP | 726 | P20585 | |
| QKLSQRHKLQPRVIK | 161 | M0R2J8 | |
| EQFKGLRKLIILHLR | 151 | Q86VH4 | |
| KIKQRLFENLRMLPH | 361 | Q13547 | |
| TKPLHVRRLQKALRE | 91 | Q15742 | |
| ALRNLEPLLKQARHV | 296 | Q86W26 | |
| NLKLNLHPFRKVRVH | 716 | A6NM62 | |
| SNPLHRLKLRLAIQE | 886 | O75145 | |
| DPKRNVRVLKIHLLA | 481 | Q8NDZ0 | |
| IKEQRILAKQLHNIP | 156 | Q5CZC0 | |
| RHRIPRLNIKTGKLE | 301 | Q9H3H5 | |
| LVPSNHLLKRKQREF | 301 | Q96JB8 | |
| SNPLHRLKLRLAIQE | 926 | Q13136 | |
| KLLPQRVLEQHKLNK | 151 | P26038 | |
| FDLPIHRRKLAQLEK | 236 | Q9H0R5 | |
| TKKQRNDVHLRTPLL | 596 | P10070 | |
| PHVERKILDLFQLNK | 121 | Q9UGL1 | |
| QIRKLLEEVQLLKPR | 1166 | P59047 | |
| RPKKQHEIRRLGELV | 131 | Q96FB5 | |
| RRKVLHRDLKPQNLL | 306 | Q00537 | |
| EHSVPKRQRIRKLQI | 71 | O00425 | |
| LLPQQVHINRLIGKK | 146 | Q15256 | |
| NIVPQALVHLLSRKK | 76 | Q9H210 | |
| KLNINISLDHKRPLI | 1481 | Q460N5 | |
| QREPKGILRHVKNLA | 1876 | Q96QU1 | |
| REAQIMKNLRHPKLI | 276 | P42685 | |
| HAKNIIRPQLKFREK | 176 | Q01780 | |
| QNRKQHISILLPKVR | 216 | Q6JEL2 | |
| NPRKLQKQIHILETR | 146 | Q8NA47 | |
| HRFNLKQRLKDKPLL | 96 | Q9H8Y5 | |
| REIRMLKQLKHPNLV | 51 | Q00532 | |
| RKVREQVLKCPQLHE | 1546 | Q8TD26 | |
| KVLHRDLKPQNLLIN | 281 | Q00536 | |
| LLKIIRHPERKGLAQ | 246 | Q9NY28 | |
| HKLLQPFLLRRVKAE | 251 | Q86WJ1 | |
| KVHQTLILDPAQRKR | 676 | Q3T8J9 | |
| IFHLQRKPRLELQIK | 586 | Q6ZMT9 | |
| RLRKNLKSLIIVHPS | 236 | Q12982 | |
| SLIKIDHLVKPRRQA | 2406 | Q8TEP8 | |
| VVRLIHLRLKLQELK | 171 | Q6ZN54 | |
| LRKLRQLEEQVKLIP | 196 | Q63ZY3 | |
| DLKVKRITPRHLQLA | 76 | P0C0S5 | |
| LELLQHKKKLRSPQI | 1211 | Q9H583 | |
| FVTLRRHKNEPLIIK | 641 | P55286 | |
| PRLEQLKTHVQVIKR | 376 | Q8WUI4 | |
| VIQKRHLEKQLLARP | 146 | Q8N4B5 | |
| SNPLHRLKLRLAIQE | 946 | O75334 | |
| EIPAIRNHDKVLQRL | 31 | Q8IWE5 | |
| SQRLKVPKERLALLH | 61 | Q504T8 | |
| HQLLESRKRKRPIQK | 226 | P43307 | |
| KALHQRVNIVPILAK | 276 | O43236 | |
| LKTIRHKLLPNLNDI | 156 | P27169 | |
| LQRKERLKPAHIHLQ | 16 | O76011 | |
| AHRNIRKFLKDQVLP | 376 | Q9NVN3 | |
| KPVQRILKYHLLLQE | 226 | A1L390 | |
| DHRLQKVKVILLLPR | 361 | Q8NE18 | |
| VSPELRRQLEQHIKK | 591 | Q8IWB4 | |
| ERNVLLKNVKHPFLV | 146 | O00141 | |
| LLGPRLLQKVEHQNK | 511 | Q86UD5 | |
| DRILPKLRATNHKVL | 1086 | P51532 | |
| PEKLKHQLRHRELFL | 96 | Q13330 | |
| NLRQKRPAILHSLKF | 126 | Q5T5C0 | |
| EIPNIQKQRKHLAKL | 131 | Q17R89 | |
| PRQNLKCVRILKQFH | 76 | O43463 | |
| KLKVLRHELSLQQPQ | 381 | Q9HCE7 | |
| KIRREIQNLKLFRHP | 71 | Q13131 | |
| HINQPALKQREAILK | 256 | Q8NBU5 | |
| EKILLRLLKHPNVIQ | 631 | Q9NRU3 | |
| RLLKHPNVIQELKFD | 636 | Q9NRU3 | |
| EKILLRLLKHPNVIQ | 646 | Q9H8M5 | |
| LERLRLNKNKLQVLP | 111 | O75094 | |
| VSPELRRQLEQHIKK | 591 | Q5VYP0 | |
| NLLNKNVPRKDLAIH | 301 | Q8IWX7 | |
| KFQLNQHRRIKLSPL | 216 | Q96HI0 | |
| HSRPQAQRVIKDLIK | 51 | Q6P589 | |
| VSPELRRQLEQHIKK | 591 | Q5TZJ5 | |
| VSPELRRQLEQHIKK | 591 | Q5VU36 | |
| HLNRKVLKRLNFSVP | 71 | Q9Y4P9 | |
| PRELQIVRTLDHKNI | 56 | Q96PN8 | |
| RLLRLKLKVEQHVEL | 156 | P01137 | |
| RAKLRRVHKNLIPQG | 76 | O75896 | |
| LHLKDFRINLPDKNV | 211 | Q9NW97 | |
| VHRQKLLEKQLPLQK | 2026 | P02549 | |
| TLEINPRHALIKKLN | 641 | Q12931 | |
| PRHALIKKLNQLRAS | 646 | Q12931 | |
| VRLTARILAKQKIHP | 106 | Q9NRG4 | |
| IENLAKILKRHPGLR | 1031 | Q5TAX3 | |
| RQLRLIAAKPDQLIK | 921 | Q9C0D4 | |
| IFKLPHLQFLELKRN | 211 | O94898 |